Andrew J. Schwab - Director, 10%+ Owner at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
ELVN on Nasdaq, IMRA on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew J. Schwab since 4/23/2024

Holdings reported by Andrew J. Schwab for Enliven Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 960K $14.5M $15.14 Feb 23, 2023 Indirect
Stock Option (right to buy) 27.6K Feb 23, 2023 Direct Common Stock

Transactions reported by Andrew J. Schwab for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.